156 Chapter 6 References 1. Gini, A, Jansen EE, Zielonke N, et al. Impact of colorectal cancer screening on cancerspecific mortality in Europe: a systematic review. European Journal of Cancer. 2020;127:224-35. 2. Jansen EE, Zielonke N, Gini A, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. European Journal of Cancer. 2020;127:207-23. 3. Zielonke N, Gini A, Jansen EE, et al. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review. European journal of cancer. 2020;127:191-206. 4. Bevolkingsonderzoek Nederland. Jaarbericht 2020. Available from: https://www. jaarberichtbevolkingsonderzoeknederland2020.nl/. Accessed December 2022. 5. Rijksinstituut voor Volksgezondheid en Milieu. Population screening programmes 2021. Available from: https://www.rivm.nl/node/99391. Accessed December 2022. 6. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Baarmoederhalskanker 2020. Available from: https://www.rivm.nl/bevolkingsonderzoekbaarmoederhalskanker/professionals/monitoring-en-evaluatie. Accessed November 2022. 7. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Borstkanker 2020. Available from: https://www.rivm.nl/bevolkingsonderzoek-borstkanker/ professionals/monitoring-en-evaluatie. Accessed November 2022. 8. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Darmkanker 2020. Available from: https://www.rivm.nl/bevolkingsonderzoek-darmkanker/ professionals/monitoring-en-evaluatie. Accessed November 2022. 9. World Health Organization. National cancer control programmes: policies and managerial guidelines: World Health Organization, 2002 10. World Health Organization. Cancer control: Early detection. WHO guide for effective programmes, 2007. 11. World Health Organization. Guide to cancer early diagnosis, 2017. 12. European Commission, Directorate-General for Research and Innovation, Group of Chief Scientific Advisors. Cancer screening in the European Union, 2022.13. 13. Bongaerts THG, Büchner FL, Middelkoop BJ, et al. Determinants of (non-) attendance at the Dutch cancer screening programmes: A systematic review. Journal of medical screening. 2020;27(3):121-9. 14. Bongaerts THG, Büchner FL, Munck de L, et al. Attendance characteristics of the breast and colorectal cancer screening programmes in a highly urbanised region of the Netherlands: a retrospective observational study. BMJ Open. 2023; currently under review. 15. Jensen LF, Mukai TO, Andersen B, et al. The association between general practitioners’ attitudes towards breast cancer screening and women’s screening participation. BMC cancer. 2012;12(1):1-6. 16. Twinn S, Cheng F. Increasing uptake rates of cervical cancer screening amongst Hong Kong Chinese women: the role of the practitioner. Journal of Advanced Nursing. 2000;32(2):335-42. 17. Rat C, Latour C, Rousseau R, et al. Interventions to increase uptake of faecal tests for colorectal cancer screening: a systematic review. European Journal of Cancer Prevention. 2018;27(3):227-36. 18. Federici A, Rossi PG, Bartolozzi F, et al. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy). Cancer Causes & Control. 2006;17(1):45-52.
RkJQdWJsaXNoZXIy MTk4NDMw